There were two successful days for Firalis and its associates Florian Still and Xavier Preville at the 12th Annual Biomarkers Congress in Manchester. Countless interested visitors met at the company’s booth in order to discuss about biomarker discovery and Xavier Preville was honored to chair Charter 1 / Stream 1 in the congress on the first day.
In line with the current industry trends, this event focused on the discovery, development and clinical development of biomarkers in therapeutic areas, such as Autoimmune, Immuno-oncology, Neuroscience, and Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Several expert speakers also covered innovations in biomarker research, such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms.
If you didn’t have the chance to meet us and you would like to discuss your interest in biomarkers, please contact us at firstname.lastname@example.org